Syneron Medical Ltd (ELOS) Posts Q3 EPS of $0.03, Sales Top Expectations
Syneron Medical Ltd (NASDAQ: ELOS) reported Q3 EPS of $0.03, which may not compare to the analyst estimate of ($0.11). Revenue for the quarter came in at $57 million versus the consensus estimate of $50.66 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Red Robin Gourmet Burgers (RRGB) Tops Q4 EPS by 4c
- SS&C Technologies (SSNC) Tops Q4 EPS by 2c; Issues Light Revenue Guidance
- Energen (EGN) Misses Q4 EPS by 11c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!